Health 45

Understanding Prostate Cancer and modern hormone therapies: what patients and caregivers should know

Prostate cancer begins in the prostate, a small gland beneath the bladder that produces seminal fluid. For many men it is a slow-growing disease that may never cause symptoms; for others it can spread (metastasize) beyond the prostate and become life-threatening. Because outcomes and treatment choices vary widely, clear patient education about how prostate cancer behaves, what to watch for, and ..

Health 2026.01.14

How Much Does Abiraterone Cost Per Month? A Patient-Focused Guide in the Philippines

For many prostate cancer patients, understanding treatment costs is just as important as understanding the medicine itself. Abiraterone acetate is an effective therapy, but people often ask practical questions such as how much is abiraterone and how much does abiraterone cost per month.Monthly Cost of Abiraterone TreatmentThe monthly expense usually depends on the prescribed dose, most commonly ..

Health 2025.12.29

Osimertinib 80 mg in the Philippines: Patient-Focused Information on Use, Effectiveness, Cost, and Access

Osimertinib 80 mg is a targeted cancer medicine commonly prescribed for certain patients with EGFR-mutated non-small cell lung cancer (NSCLC). In the Philippines, many patients and caregivers search for clear, reliable information about how this medicine works, how effective it is, what side effects to expect, and very practically how much Osimertinib costs and where it can be accessed locally.T..

Health 2025.12.23

Enzalutamide for Prostate Cancer – Uses, Side Effects & Price in the Philippines

Enzalutamide 160 mg is one of the widely prescribed anti-androgen medicines used for metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Many patients choose Enzalutamide because it helps slow cancer progression, reduces tumor growth, and improves quality of life. In some cases, studies show that enzalutamide may extend survival when ..

Health 2025.12.06